Cargando…
Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen
There are no effective treatment options for most patients with metastatic colorectal cancer (mCRC). mCRC remains a leading cause of tumor-related death, with a five-year survival rate of only 15%, highlighting the urgent need for novel pharmacological products. Current standard drugs are based on c...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228411/ https://www.ncbi.nlm.nih.gov/pubmed/37243574 http://dx.doi.org/10.1080/19420862.2023.2217964 |